Evidence map›Paper›PMID 25901736›Full record

ArticlePloS one2015

Serpine2/PN-1 Is Required for Proliferative Expansion of Pre-Neoplastic Lesions and Malignant Progression to Medulloblastoma.

Catherine Vaillant, Paola Valdivieso, Sandro Nuciforo, Marcel Kool, Alexandra Schwarzentruber-Schauerte, Hélène Méreau, Erik Cabuy, Johannes A Lobrinus, Stefan Pfister, Aimée Zuniga and 2 more

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 20 papers.

0numbers the graph read from it
0cells of the map it votes in
20citing papers in PubMed
1.5field-weighted citation impact, top 18% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

20 citing papers in PubMed, 24 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Review
  7. Article
  8. Article
  9. Article
  10. Review
  11. Article
  12. Article
  13. Review
  14. Medulloblastoma, WNT-activated/SHH-activated: clinical impact of molecular analysis and histogenetic evaluation.Child's nervous system : ChNS : official journal of the International Society for Pediatric Neurosurgery · 2018
    Review
  15. Expression pattern of humanOncology letters · 2018
    Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Serpine2, a potential novel target for combating melanoma metastasis.American journal of translational research · 2016
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 4 institutions in 2 countries.

Catherine VaillantDevelopmental Genetics, Department of Biomedicine, University of Basel, Basel, Switzerland.
Paola ValdiviesoDevelopmental Genetics, Department of Biomedicine, University of Basel, Basel, Switzerland.
Sandro NuciforoDevelopmental Genetics, Department of Biomedicine, University of Basel, Basel, Switzerland.
Marcel KoolDivision of Pediatric Neuro-Oncology, German Cancer Research Center DKFZ, Heidelberg, Germany.
Alexandra Schwarzentruber-SchauerteDevelopmental Genetics, Department of Biomedicine, University of Basel, Basel, Switzerland.
Hélène MéreauDevelopmental Genetics, Department of Biomedicine, University of Basel, Basel, Switzerland.
Erik CabuySingle Cell Genomics, Friedrich Miescher Institute, Basel, Switzerland.
Johannes A LobrinusNeuropathology Unit, Department of Clinical Pathology, University Hospital Geneva, Geneva, Switzerland.
Stefan PfisterDivision of Pediatric Neuro-Oncology, German Cancer Research Center DKFZ, Heidelberg, Germany.
Aimée ZunigaDevelopmental Genetics, Department of Biomedicine, University of Basel, Basel, Switzerland.
Stephan FrankDivision of Neuropathology, Institute of Pathology, University of Basel, Basel, Switzerland.
Rolf ZellerDevelopmental Genetics, Department of Biomedicine, University of Basel, Basel, Switzerland.
University of Basel · CHHeidelberg University · DEFriedrich Miescher Institute · CHUniversity Hospital of Geneva · CH

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundMedulloblastomas are malignant childhood brain tumors that arise due to the aberrant activity of developmental pathways during postnatal cerebellar development and in adult humans. Transcriptome analysis has identified four major medulloblastoma subgroups. One of them, the Sonic hedgehog (SHH) subgroup, is caused by aberrant Hedgehog signal transduction due to mutations in the Patched1 (PTCH1) receptor or downstream effectors. Mice carrying a Patched-1 null allele (Ptch1∆/+) are a good model to study the alterations underlying medulloblastoma development as a consequence of aberrant Hedgehog pathway activity.

resultsTranscriptome analysis of human medulloblastomas shows that SERPINE2, also called Protease Nexin-1 (PN-1) is overexpressed in most medulloblastomas, in particular in the SHH and WNT subgroups. As siRNA-mediated lowering of SERPINE2/PN-1 in human medulloblastoma DAOY cells reduces cell proliferation, we analyzed its potential involvement in medulloblastoma development using the Ptch1∆/+ mouse model. In Ptch1∆/+ mice, medulloblastomas arise as a consequence of aberrant Hedgehog pathway activity. Genetic reduction of Serpine2/Pn-1 interferes with medulloblastoma development in Ptch1∆/+ mice, as ~60% of the pre-neoplastic lesions (PNLs) fail to develop into medulloblastomas and remain as small cerebellar nodules. In particular the transcription factor Atoh1, whose expression is essential for development of SHH subgroup medulloblastomas is lost. Comparative molecular analysis reveals the distinct nature of the PNLs in young Ptch1∆/+Pn-1Δ/+ mice. The remaining wild-type Ptch1 allele escapes transcriptional silencing in most cases and the aberrant Hedgehog pathway activity is normalized. Furthermore, cell proliferation and the expression of the cell-cycle regulators Mycn and Cdk6 are significantly reduced in PNLs of Ptch1∆/+Pn-1Δ/+ mice.

conclusionsOur analysis provides genetic evidence that aberrant Serpine2/Pn-1 is required for proliferation of human and mouse medulloblastoma cells. In summary, our analysis shows that Serpine2/PN-1 boosts malignant progression of PNLs to medulloblastomas, in which the Hedgehog pathway is activated in a SHH ligand-independent manner.

Indexed as

Disease ProgressionAnimalsCell Line, TumorCell ProliferationCerebellumDisease Models, AnimalGene SilencingGenotypeHedgehog ProteinsHumansMatrix Metalloproteinase 9MedulloblastomaMice, Inbred C57BLPatched-1 ReceptorPatched ReceptorsPrecancerous ConditionsHedgehog ProteinsMatrix Metalloproteinase 9Patched-1 ReceptorPatched ReceptorsPTCH1 protein, humanPtch1 protein, mouseReceptors, Cell SurfaceSerpin E2

Identifiers

PMID25901736
PMCPMC4406471
OpenAlexW1971511668

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.